Competition

John LaMattian, former head of Pfizer R&D, says industry mergers have harmed R&D efforts

Posted on by James Love

John L. LaMattina, the former President of Pfizer Global Research and Development, has just published an article in Nature that looks at the impact of drug company mergers and increased industry concentration on R&D. Among his conclusions: the “impact on the R&D of the organizations involved has been devastating.”

http://www.nature.com/nrd/journal/v10/n8/full/nrd3514.html

COMMENT

NATURE REVIEWS | DRUG DISCOVERY VOLUME 10 | AUGUST 2011 | 559

The impact of mergers on pharmaceutical R&D

Continue Reading →

59 U.S. Senators write the EU to support Oracle acquisition of MYSQL

Posted on by James Love

On the 24th of November, 59 U.S. Senators wrote the European Union, asking that the Oracle/Sun merger be allowed, without addressing the anticompetitive aspects of the Oracle acquisition of MySQL. The letter reflects the enormous influence wielded by Oracle, a company that generates enormous fees licensing database software to the federal government. Continue Reading →

KEI, Richard Stallman, ORG, letter to European Commission opposing Oracle acquisition of MySQL assets from Sun

Posted on by James Love

KEI, Richard Stallman, ORG, letter to European Commission opposing Oracle acquisition of MySQL assets from Sun The following is a letter that KEI, Richard Stallman and ORG have sent to the European Commission, asking the European Commission to prevent Oracle… Continue Reading →